Dow Down 0.82% Nasdaq Down 0.93%

Celgene Corporation (CELG)

-NasdaqGS
93.59 Down 1.19(1.26%) 10:17AM EDT - Nasdaq Real Time Price
Prev Close:94.78
Open:95.24
Bid:93.76 x 200
Ask:93.82 x 100
1y Target Est:103.80
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:93.12 - 95.39
52wk Range:66.85 - 96.50
Volume:662,937
Avg Vol (3m):4,343,620
Market Cap:74.83B
P/E (ttm):54.10
EPS (ttm):1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 1.26%74.83B
JNJDown 1.53%296.02B

Key Statistics

Forward P/E (1 yr):19.18
P/S (ttm):10.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback